PROTACs is an emerging strategy for targeted therapy in drug discovery. After target protein degradation, PROTAC is released and continues the degradation process. Thus, toxicological issue is one of the main challenges for PROTACs application in drug delivery. Cell cytotoxicity assay is a common method in investigation of the toxicity of molecules on cellular systems, Profacgen offers multiple assays to help our clients address this issue in vitro.

https://www.profacgen.com/cell-cytotoxicity-test.htm

Profacgen offers a full range of biopharmaceutical development and bio-manufacturing services that cover strategic consultancy, world-class process development, cGMP manufacturing, and analytical development.